• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    More On SAN.PA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Sanofi (SAN.PA)

    -Paris
    91.69 Up 0.31(0.34%) Mar 27
    Add to Portfolio
    Prev Close:91.69
    Open:91.19
    Bid:91.66
    Ask:91.69
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:89.88 - 92.49
    52wk Range:69.58 - 92.49
    Volume:3,742,364
    Avg Vol (3m):N/A
    Market Cap:119.88B
    P/E (ttm):27.78
    EPS (ttm):3.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in EUR.

    Headlines

    ┬╗ More Headlines for SAN.PA

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, including Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback